WHO ICTRP trial
A randomized, double-blind, multicenter, phase III study of Pro-NETU for the…
JPRN-jRCT2080224620 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCT2080224620 |
|---|---|
| Public title | A randomized, double-blind, multicenter, phase III study of Pro-NETU for the prevention of chemotherapy induced nausea and vomiting (CINV) in patients receiving AC/EC based highly emetogenic chemotherapy |
| Scientific title | A randomized, double-blind, multicenter, phase III study of Pro-NETU for the prevention of chemotherapy induced nausea and vomiting (CINV) in patients receiving AC/EC based highly emetogenic chemotherapy |
| Primary sponsor | Taiho Pharmaceutical Co., Ltd. |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 3 |
| Countries | Japan |
| Conditions | Chemotherapy-induced nausea and vomiting |
| Interventions | investigational material(s) Generic name etc : Pro-NETU INN of investigational material : fosnetupitant Therapeutic category code : 239 Other agents affecting digestive organs Dosage and Administration for Investigational material… |
| Registration date | Mar 29, 2019 |
| Target size | 100 |
| Secondary IDs | JapicCTI-194691 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: